On the 12th of January 2026 (14:00 – 14:30), Claudia Beltran Mestres, from the Berlin Center for Advanced Therapies at Charité Universitätsmedizin Berlin will present in our CTGCT Science Talks webinar series.
The talk is titled “Automation of Antiviral T cell Product Manufacturing“
Fill up the form to register and receive the link to the webinar on the day of the talk.
A bit about Claudia Beltran Mestre:
Claudia Beltran Mestres completed her Bachelor’s degree at the University of Girona, where she developed a strong foundation in biomedical sciences. During her studies, she spent an Erasmus period at Ghent University, focusing on Immunology and Medical Biotechnology, which deepened her interest in cellular therapies and translational immunology. She went on to earn a Master’s degree in Advanced Immunology at the University of Barcelona, further expanding her expertise in immune cell engineering, immune regulation, and medical immunology.
Following her graduate training, she joined Dr. Leila Amini’s research group at the Berlin Center for Regenerative Therapies (BeCAT), Charité – Universitätsmedizin Berlin, where she is now a third-year PhD student. The group investigates the feasibility and therapeutic potential of virus-specific T cells as a cell therapy, as well as regulatory T cells for improving outcomes in patients after solid organ transplantation.
Claudia’s presentation will focus on optimizing a GMP-ready expansion protocol for CMV-specific T cells, comparing G-Rex versus 24-well plate systems, with the goal of supporting the clinical translation of these therapies and improving immune reconstitution, reducing viral complications, and promoting transplant tolerance.
The webinar will be recorded and it might be shared only partially or fully.